淋球菌对头孢菌素耐药的治疗应对措施 |
| |
引用本文: | 王鑫,苏晓红,蒋娟. 淋球菌对头孢菌素耐药的治疗应对措施[J]. 中华皮肤科杂志, 2016, 0(5): 367-371. DOI: 10.3760/cma.j.issn.0412-4030.2016.05.020 |
| |
作者姓名: | 王鑫 苏晓红 蒋娟 |
| |
作者单位: | 中国医学科学院北京协和医学院皮肤病医院性病科,南京,210042 |
| |
基金项目: | 美国国立卫生研究院(NIH)资助项目(1-U19AI-084048)National Institutes of Health Grant Program(1-U19AI-084048) |
| |
摘 要: | 淋病是淋球菌感染引起的性传播疾病之一,对人类健康及社会经济发展均有较大的危害.近年来,由于治疗不当、患者有耐药基因等多种原因,淋球菌逐渐对青霉素、四环素、环丙沙星等抗菌药出现耐药.目前头孢菌素为治疗淋球菌感染的一线药物,随着头孢菌素的广泛应用,淋球菌对其敏感性逐渐降低,出现临床治疗淋病失败的病例.为了进一步控制淋病,应对淋球菌耐药现象,临床已出现联合治疗、替代疗法、新药研发等方案,以期为控制对头孢菌素耐药的淋病治疗提供应对策略.
|
关 键 词: | 淋病奈瑟球菌 头孢菌素类 抗药性 治疗应用 药物替代 |
Management of cephalosporin resistance in Neisseria gonorrhoeae |
| |
Abstract: | Gonorrhea is a sexually transmitted disease caused by Neisseria gonorrhoeae,and substantially harms human health and socioeconomic development.Due to inappropriate treatment and the presence of drug resistance genes in patients,antibiotic resistance has emerged in Neisseria gonorrhoeae,such as resistance to penicillin,tetracycline,ciprofloxacin,or other antibiotics.Currently,extended-spectrum cephalosporins (ESCs) are the first-line treatment of gonococcal infection.With the wide use of ESCs,the sensitivity of Neisseria gonorrhoeae to ESCs has been decreasing gradually,and there have been reports on cases of treatment failure in clinical practice.In order to control gonorrhea and deal with drug resistance in Neisseria gonorrhoeae,combined therapy,alternative therapy and new drugs have been developed in clinic. |
| |
Keywords: | Neisseria gonorrhoeae Cephalosporins Drug resistance Therapeutic uses Drug substitution |
本文献已被 万方数据 等数据库收录! |
|